SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-025110
Filing Date
2024-10-15
Accepted
2024-10-15 13:45:05
Documents
1
Period of Report
2024-10-10

Document Format Files

Seq Description Document Type Size
1 form4-10152024_011001.html 4  
1 form4-10152024_011001.xml 4 8076
  Complete submission text file 0001415889-24-025110.txt   9544
Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Issuer) CIK: 0001907108 (see all company filings)

IRS No.: 854012572 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O LEXEO THERAPEUTICS, INC. 345 PARK AVENUE SOUTH, 6TH FLOOR NEW YORK NY 10010
Business Address
Townsend Richard Nolan (Reporting) CIK: 0001995218 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41855 | Film No.: 241371200